Cite
Reporting quality and risk of bias of randomized controlled trials of Chinese herbal medicine for multiple sclerosis.
MLA
Jing-Ying Wu, et al. “Reporting Quality and Risk of Bias of Randomized Controlled Trials of Chinese Herbal Medicine for Multiple Sclerosis.” Frontiers in Immunology, Sept. 2024, pp. 1–19. EBSCOhost, https://doi.org/10.3389/fimmu.2024.1429895.
APA
Jing-Ying Wu, Jiang-Li Yang, Jia-Ling Hu, Shan Xu, Xiao-Jie Zhang, Shi-Yan Qian, Min-Li Chen, Ali, M. A., Juan Zhang, Zheng Zha, & Guo-Qing Zheng. (2024). Reporting quality and risk of bias of randomized controlled trials of Chinese herbal medicine for multiple sclerosis. Frontiers in Immunology, 1–19. https://doi.org/10.3389/fimmu.2024.1429895
Chicago
Jing-Ying Wu, Jiang-Li Yang, Jia-Ling Hu, Shan Xu, Xiao-Jie Zhang, Shi-Yan Qian, Min-Li Chen, et al. 2024. “Reporting Quality and Risk of Bias of Randomized Controlled Trials of Chinese Herbal Medicine for Multiple Sclerosis.” Frontiers in Immunology, September, 1–19. doi:10.3389/fimmu.2024.1429895.